Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Canine leishmaniosis. Modulation of macrophage/lymphocyte interactions by L. infantum.

Diaz S, da Fonseca IP, Rodrigues A, Martins C, Cartaxeiro C, Silva MJ, de Brito TV, Alexandre-Pires G, Santos-Gomes GM.

Vet Parasitol. 2012 Oct 26;189(2-4):137-44. doi: 10.1016/j.vetpar.2012.05.004. Epub 2012 May 15.

PMID:
22698797
3.

Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.

Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G.

Vaccine. 2007 May 22;25(21):4223-34. Epub 2007 Mar 15.

PMID:
17395339
4.

Cutaneous immune mechanisms in canine leishmaniosis due to Leishmania infantum.

Papadogiannakis EI, Koutinas AF.

Vet Immunol Immunopathol. 2015 Feb 15;163(3-4):94-102. doi: 10.1016/j.vetimm.2014.11.011. Epub 2014 Nov 20. Review.

PMID:
25555497
5.

Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis.

Holzmuller P, Cavaleyra M, Moreaux J, Kovacic R, Vincendeau P, Papierok G, Lemesre JL.

Vet Immunol Immunopathol. 2005 Jul 15;106(3-4):247-57.

PMID:
15963823
6.

Infection of a canine macrophage cell line with leishmania infantum: determination of nitric oxide production and anti-leishmanial activity.

Pinelli E, Gebhard D, Mommaas AM, van Hoeij M, Langermans JA, Ruitenberg EJ, Rutten VP.

Vet Parasitol. 2000 Oct 1;92(3):181-9.

PMID:
10962155
7.

Transcription of innate immunity genes and cytokine secretion by canine macrophages resistant or susceptible to intracellular survival of Leishmania infantum.

Turchetti AP, da Costa LF, Romão Ede L, Fujiwara RT, da Paixão TA, Santos RL.

Vet Immunol Immunopathol. 2015 Jan 15;163(1-2):67-76. doi: 10.1016/j.vetimm.2014.11.010. Epub 2014 Nov 20.

PMID:
25466388
8.

Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes.

Panaro MA, Acquafredda A, Lisi S, Lofrumento DD, Mitolo V, Sisto M, Fasanella A, Trotta T, Bertani F, Consenti B, Brandonisio O.

Comp Immunol Microbiol Infect Dis. 2001 Jul;24(3):187-95.

PMID:
11440191
9.

Cytokine gene expression in the tissues of dogs infected by Leishmania infantum.

Barbosa MA, Alexandre-Pires G, Soares-Clemente M, Marques C, Rodrigues OR, De Brito TV, Da Fonseca IP, Alves LC, Santos-Gomes GM.

J Comp Pathol. 2011 Nov;145(4):336-44. doi: 10.1016/j.jcpa.2011.03.001. Epub 2011 Apr 20.

PMID:
21511273
10.

Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.

Strauss-Ayali D, Baneth G, Shor S, Okano F, Jaffe CL.

Int J Parasitol. 2005 Jan;35(1):63-73. Epub 2004 Dec 8.

PMID:
15619517
11.

[Interpretation of laboratory data during cryptic leishmaniasis in dog].

Gravino AE.

Parassitologia. 2004 Jun;46(1-2):227-9. Italian.

PMID:
15305723
12.

In vitro binding and survival assays of Leishmania parasites to peripherical blood monocytes and monocyte-derived macrophages isolated from dogs naturally and experimentally infected with Leishmania (Leishmania) chagasi.

Sampaio WM, Moura EP, Arruda FC, Ribeiro RR, Alves CF, Melo FA, Fernandes AP, Michalick MS, Melo MN, Tafuri WL, Tafuri WL.

BMC Vet Res. 2007 May 30;3:11.

13.

Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the L-arginine nitric oxide pathway.

Vouldoukis I, Drapier JC, Nüssler AK, Tselentis Y, Da Silva OA, Gentilini M, Mossalayi DM, Monjour L, Dugas B.

Antimicrob Agents Chemother. 1996 Jan;40(1):253-6.

14.

Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes.

Lemesre JL, Holzmuller P, Cavaleyra M, Gonçalves RB, Hottin G, Papierok G.

Vaccine. 2005 Apr 22;23(22):2825-40.

PMID:
15780731
15.
16.

Identification of two highly performing Leishmania infantum antigens for serodiagnosis of canine leishmaniosis.

Rami M, Atarhouch T, Dakkak A.

Vet Parasitol. 2005 Nov 25;134(1-2):25-31. Epub 2005 Aug 1.

PMID:
16076527
17.
18.

Canine leishmaniasis. Immunophenotypic profile of leukocytes in different compartments of symptomatic, asymptomatic and treated dogs.

Alexandre-Pires G, de Brito MT, Algueró C, Martins C, Rodrigues OR, da Fonseca IP, Santos-Gomes G.

Vet Immunol Immunopathol. 2010 Oct 15;137(3-4):275-83. doi: 10.1016/j.vetimm.2010.06.007. Epub 2010 Jun 16.

PMID:
20615553
19.

Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.

Pinelli E, Gonzalo RM, Boog CJ, Rutten VP, Gebhard D, del Real G, Ruitenberg EJ.

Eur J Immunol. 1995 Jun;25(6):1594-600.

PMID:
7614987
20.

Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.

Vouldoukis I, Rougier S, Dugas B, Pino P, Mazier D, Woehrlé F.

Vet Parasitol. 2006 Jan 30;135(2):137-46. Epub 2005 Oct 19.

PMID:
16242844

Supplemental Content

Support Center